Discover 2,163 paid clinical trials in Carlsbad, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,163
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
for
NSCLC (Advanced Non-small Cell Lung Cancer)
Location: La Jolla CA, Irvine CA, Phoenix AZ, Stanford CA,
Sponsor: BlossomHill Therapeutics
Sex: All
Age: 18+
Code: NCT06706076
Phase 1, Phase 2, Recruiting
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
for
Advanced Melanoma
Location: La Jolla CA, Orange CA, Los Angeles CA, Gilbert AZ,
Sponsor: Replimune, Inc.
Sex: All
Age: 12+
Code: NCT06264180
Phase 3, Recruiting
Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System
for
Locally Recurrent Skin Squamous Cell Carcinoma,
Location: La Jolla CA, Los Angeles CA, Gilbert AZ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07042295
Phase 2, Recruiting
Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
for
Intracranial Meningioma
Location: La Jolla CA, Irvine CA, Houston TX, Iowa City IA,
Sponsor: RTOG Foundation, Inc.
Sex: All
Age: 18+
Code: NCT06955169
Phase 2, Recruiting
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
for
Astrocytoma, IDH-Mutant, Grade 2,
Location: La Jolla CA, Irvine CA, Orange CA, Duarte CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06860594
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Location: La Jolla CA, San Diego CA, Irvine CA, Orange CA,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: Male
Age: 18+
Code: NCT07200830
Phase 3, Recruiting
Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer
for
Prostate Cancer,
Location: La Jolla CA, Dallas TX, St Louis MO, Nashville TN,
Sponsor: Janux Therapeutics
Sex: Male
Age: 18+
Code: NCT07545811
Phase 1, Recruiting
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
for
Recurrent Glioblastoma, IDH-Wildtype,
Location: La Jolla CA, Duarte CA, Los Angeles CA, Phoenix AZ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05432804
Phase 1, Phase 2, Recruiting
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative,
Location: La Jolla CA, Irvine CA, Orange CA, Duarte CA, Nampa ID,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT03739814
Phase 2, Recruiting
A Multi-Center Observational Trial of Symptomatic, High-Risk Bone Metastases Treated With Percutaneous Ablation and Palliative Radiation Therapy
for
Bone Cancer Metastatic
Location: San Diego CA, Rochester MN, St Louis MO, Milwaukee WI,
Sponsor: Society of Interventional Oncology
Sex: All
Age: 21+
Code: NCT06859801
Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: La Jolla CA, Irvine CA, Orange CA, Sacramento CA,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT07097142
Phase 3, Recruiting
A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
Location: San Diego CA, Los Angeles CA, San Francisco CA,
Sponsor: Pierre Fabre Medicament
Sex: All
Age: 18+
Code: NCT04913285
Phase 1, Recruiting
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
for
Locally Advanced Adrenal Cortical Carcinoma,
Location: La Jolla CA, Madera CA, Phoenix AZ, Aurora CO,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12+
Code: NCT06900595
Phase 2, Recruiting
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
for
Breast Neoplasms
Location: La Jolla CA, Los Alamitos CA, Los Angeles CA,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT07173751
Phase 3, Recruiting
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
for
Prostate Cancer (Adenocarcinoma),
Location: La Jolla CA, Duarte CA, Seattle WA, Minneapolis MN,
Sponsor: Prostate Cancer Clinical Trials Consortium